Predictive 3D-quantitative structure-activity relationship for A 1 and A2A adenosine receptor ligands

QSAR and Combinatorial Science

Volumn 28, Issue 11-12, 2009, Pages 1442-1454

  Yuzlenko, Olga ^a   Drabczyńska, Anna ^a   Kieć Kononowicz, Katarzyna ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

3D QSAR; Adenosine receptor; Bioinformatics; Computational chemistry; Hybrid shape property descriptors; Model validation; Molecular descriptors; Xanthine ligands

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; BENZYL DERIVATIVE; HALOGEN; LIGAND; PROPANE; XANTHINE DERIVATIVE;

ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; DRUG STRUCTURE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; STATISTICAL MODEL; THREE DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION STUDY;

EID: 76049090888     PISSN: 1611020X     EISSN: 16110218     Source Type: Journal    
DOI: 10.1002/qsar.200910047     Document Type: Article

References (43)

1. B. B. Fredholm, A. P. Ijzerman, K. A. Jacobson, K. N. Klotz, J. Linden, Pharm. Rev. 2001, 53, 527-552.
2. C. E. Müller, Curr. Pharm. Des. 2002, 8, 2353-2369.
3. A. Brunschweiger, C. E. Müller. Curr. Med. Chem. 2006, 13, 289-312.
4. C. E. Müller, Expert Opin. Ther. Patents 1997, 7, 419-440.
5. S. Hess, Expert Opin. Ther. Patents, 2001, 11, 1533-1561.
6. R. A. Cuncha, Purinergic Signalling, 2005, 1, 111-134.
7. G. Cristalli, C. E. Müller, R. Volpini, in Handbook for Experimental Pharmacology, Vol. 193, Adenosine Receptors in Health and Disease, Springer, Berlin 2009, pp. 59-98.
8. L. Yu, H.-Y. Shen, J. E. Coelho, I. M. Araújo, Q.-Y. Huang, Y.-J. Day, N. Rebola, P. M. Canas, E. Kirsten Rapp, J. Ferrara, D. Taylor, C. E. Müller, J. Linden, R. A. Cunha, J.-F. Chen, Ann. Neurol. 2008, 63, 338-346.
9. J. D. Salamone, A. J. Betz, K. Ishiwari, J. Felsted, L. Madson, B. Mirante, K. Clark, L. Font, S. Korbey, T. N. Sager, J. Hockemeyer, C. E. Müller, Front. Biosci. 2008, 13, 3594-3605.
10. K. Fuxe, D. Marcellino, S. Genadani, L. Agnati, Mov. Disord. 2007, 22, 1990-2017.
11. K. Ishiwari, L. J. Madson, A. M. Farrar, S. M. Mingote, J. P. Valenta, M. D. DiGianvittorio, L. E. Frank, M. Correa, J. Hockemeyer, C. E. Müller, J. D. Salamone, Behavioural Brain Res. 2007, 178, 190-199.
12. C. E. Müller, S. Ferré, Recent Patents on CNS Drug Discovery, 2007, 2, 1-21.
13. B. Cacciari, G. Pastorin, G. Spalluto, Curr. Top. Med. Chem. 2003, 3, 403-411.
14. K. Kieć-Kononowicz, A. Drabczyńska, E. Pȩkala; B. Michalak; C. E. Müller, B. Schumacher, J. Karolak-Wojciechowska, H. Duddeck, S. Rockitt, R. Wartchow, Pure Appl. Chem. 2001, 73, 1411-1420.
15. A. Drabczyńska, C. E. Müller, S. K. Lacher, B. Schumacher, J. Karolak-Wojciechowska, A. Nasal, P. Kawczak, O. Yuzlenko, E. Pȩkala, K. Kieć-Kononowicz, Bioorg. Med. Chem. 2006, 14, 7258-7281.
16. A. Drabczyńska, C. E. Müller, J. Karolak-Wojciechowska, B. Schumacher, A. Schiedel, O. Yuzlenko, K. Kieć-Kononowicz, Bioorg. Med. Chem. 2007, 15, 5003-5017.
17. A. Drabczyńska, C. E. Müller, A. Schiedel, B. Schumacher, J. Karolak-Wojciechowska, A. Fruziński, W. Zobnina, O. Yuzlenko, K. Kieć-Kononowicz, Bioorg. Med. Chem. 2007, 15, 6956-6974.
18. S. Rockitt, H. Duddeck, A. Drabczyńska, K. Kieć-Kononowicz, Eur. J. Org. Chem. 2000, 3489-3496.
19. 2A Adenosine Receptor Ligands", Dissert. Pharm. Krakow 2008, ch. 3, 48-64.
20. U. Geis, B. Grahner, M. Pawłowski, A. Drabczyńska, M. Gorczyca, C. E. Müller, Pharmazie 1995, 50, 333-336.
21. A. Masamoto, H. Kiyoshi, F. Kimito, Curr. Comp. Aided Drug Des. 2007, 3, 254-262.
22. M. Karelson, V. S. Lobanov, A. R. Katritzky, Chem. Rev. 1996, 96, 1027-1043.
23. A. Golbraikh, M. Shen, Z. Xiao, Y.-De Xiao, K.-H. Lee, A. Tropsha, J. Comp. Aided Mol. Des. 2003, 17, 241-253.
24. D. M. Hawkins, S. C. Basak, D. Mills, J. Chem. Inf. Comput. Sci. 2003, 43, 579-586
25. A. Golbraikh, A. Tropsha, J. Mol. Graph. Model. 2002, 20, 269-276.
26. CAChe Worksystem Pro 7.6. CAChe Group, Fujitsu America, USA, 2006.
27. A. D. Becke, Phys. Rev. B 1988, 38, 3098-3100.
28. C. Lee, W. Yang, R. G. Parr, Phys. Rev. 1988, 37, 785-789
29. W. Koch, M. C. Holthausen. A Chemist's Guide to Density Functional Theory, Wiley-VCH, Weinheim 2001, p. 75.
30. L. B. Kier, L. H. Hall, Molecular Connectivity in Structure-Activity Analysis, Wiley, New York 1986.
31. A. K. Ghose, A. Pritchett, G. M. Crippen, J. Comp. Chem. 1988, 9, 80-90.
32. L. H. Hall, L. B. Kier, Reviews in Computational Chemistry (Eds: K. B. Lipkowitz, D. B. Boyd, Wiley-VCH, Weinheim 1992, ch. 9.
33. S. J. Vosko, L. Wilk, M. Nusair, Can. J. Phys. 1980, 58, 1200-1211.
34. F. Jensen, Introduction to Computational Chemistry, Wiley, Chichester 2001, pp. 350-378.
35. A. Klamt, G. Schuurmann, J. Chem. Soc. Perkin Trans. 2, 1993, 5, 799-805.
36. T. Clark, A Handbook of Computational Chemistry, Wiley, New York 1985, ch. 1, pp. 1-33.
37. D. M. Hawkins, J. Chem. Inf. Comput. Sci. 2004, 44, 1-12.
38. L. He, P. C. Jurs, J. Mol. Graph. Model. 2005, 23, 503-523.
39. M. T. Cronin, T.W. Schultz, THEOCHEM . 2003, 622, 39-51
40. M. Snarey, N. K. Terrent, P. Willett, D. J. Wilton, J. Mol. Graph. Mod. 1997, 15, 372-385.
41. A. Golbraikh, A. Tropsha, J. Comp. Aided Mol. Des. 2002, 16, 357-369.
42. K. Breneman, C. M. Sundling, N. Sukumar, L. Shen, W. P. Katt, M. J. Embrechts, J. Comp. Aided Mol. Des. 2003, 17, 231-240.
43. R. P. Verma, C. Hansch, Bioorg. Med. Chem. 2005, 13, 4597-4621.